Mayo Clinic Sells Mobile Platform | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Mayo Clinic Sells Mobile Platform

June 14, 2012
by Gabriel Perna
| Reprints

Mayo Clinic has sold mRemedy, a company formed by Mayo and DoApp Inc. that offers a mobile healthcare platform to providers, to Axial Exchange, a Raleigh, N.C.-based virtual software-as-a-service company. The platform, myTality, aims to help patients navigate future hospital visits, and help hospitals better market their services. Axial plans on using it in conjunction with its care-transition platforms, Axial Patient and Axial Provider.

The deal, brokered by Axial’s lead venture capital investor Canaan Partners, provides the vendor with with access to consumer content from MayoClinic.com, which offers patients various general healthcare related information, including stuff on nearly 1,000 conditions and diseases.

In addition, four Mayo Clinic physicians will join Axial’s Advisory Board including Paul Y. Takahashi, M.D.; Nathan Jacobson, D.O., and two others to be named.

“Patients and their families want and expect the most up-to-date information about life, health, disease and treatment,” Dr. Paul Takahashi, associate professor of medicine at Mayo Clinic, said in a statement. “Mayo Clinic’s health information content will now reach even more people, providing accurate answers to common and uncommon health issues.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).